发明名称 SOLID PHASE PEPTIDE SYNTHESIS OF INSULIN USING SIDE CHAIN ACHORED LYSINE
摘要 The present application discloses the preparation of peptides, including insulin and insulin derivatives, using efficient methods for solid-phase and solution phase peptide synthesis.
申请公布号 US2016031962(A1) 申请公布日期 2016.02.04
申请号 US201214395313 申请日期 2012.04.20
申请人 BARLOS Kleomenis K. 发明人 Barlos Kleomenis K.
分类号 C07K14/62;C07K1/04 主分类号 C07K14/62
代理机构 代理人
主权项 1. A lysine-resin conjugate comprising a resin and a lysine or a lysine derivative of the formula I: wherein W is an acid sensitive or thermal sensitive resin, or a resin that is both acid and thermal sensitive toward cleavage of the lysine or lysine derivative from the resin; R is selected from the group consisting of —OH, a carboxyl protecting group, —NH2, —O—C1-6 alkyl, —O—C2-6 alkenyl, —O-tri-C1-3 alkyl silyl, a peptide residue selected from the group consisting of -Pro-OH, -Pro-NH2, -Pro-O—C1-6 alkyl, -Pro-O—C2-6alkenyl, -Pro-O-tri-C1-3 alkylsilyl, Thr(Pr1), -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-OH, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-NH2, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-O—C1-6 alkyl, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-O—C2-6 alkenyl, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-O-tri-C1-3 alkylsilyl, -Thr(Pr1)-OH, -Thr(Pr1)-NH2, -Thr(Pr1)-O—C1-6 alkyl, -Thr(Pr1)-O—C2-6 alkenyl and -Thr(Pr1)-O-tri-C1-3alkylsilyl, a peptide residue comprising 1 to 200 amino acids comprising optionally protected side chain and optionally protected terminal carboxyl group, and a peptide residue selected from the group consisting of SEQ ID NOs: 1, 3, 4, 5, 6, 7, 8, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 and 36; wherein Pr1 is an —OH protecting group and each Pr2 and Pr3 is independently hydrogen or a guanidine protecting group; and P is hydrogen, an amino protecting group, an N-terminus peptide residue comprising 1 to 200 amino acids comprising optionally protected side chain and optionally protected terminal amino group, wherein the N-terminus peptide residue comprises a C-terminus and an N-terminus, and a peptide residue selected from the group consisting of SEQ ID NOs: 1, 3, 4, 5, 6, 7, 8, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 and 36; provided that when R is selected from the group consisting of —OH, a carboxyl protecting group, —NH2, —O—C1-6 alkyl, —O—C2-6 alkenyl, —O-tri-C1-3 alkyl silyl, a peptide residue selected from the group consisting of -Pro-OH, -Pro-NH2, -Pro-O—C1-6 alkyl, -Pro-O—C2-6 alkenyl, -Pro-O-tri-C1-3 alkylsilyl, Thr(Pr1), -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-OH, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-NH2, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-O—C1-6 alkyl, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-O-C2-6 alkenyl, -Thr(Pr1)-Arg(Pr2)-Arg(Pr3)-O-tri-C1-3 alkylsilyl, -Thr(Pr1)-OH, -Thr(Pr1)-NH2, -Thr(Pr1)-O—C1-6 alkyl, -Thr(Pr1)-O—C2-6 alkenyl and -Thr(Pr1)-O-tri-C1-3 alkylsilyl, and a peptide residue comprising 1 to 200 amino acids comprising optionally protected side chain and optionally protected terminal carboxyl group, then P is not hydrogen or an amino protecting group.
地址 Patras GR